🤯 Have you seen our AI stock pickers’ 2024 results? 84.62%! Grab November’s list now.Pick Stocks with AI

UPDATE 4-European shares hit 8-month high on renewed vaccine hopes

Published 09-11-2020, 01:48 pm
Updated 09-11-2020, 11:00 pm
© Reuters.
UK100
-
DE40
-
IFXGn
-
TW
-
PFE
-
FTMC
-
STOXX
-
SXTP
-
BNTX
-

* STOXX 600 logs best day in nearly six months

* Travel and leisure stocks among best performers

* Trade-reliant miners, auto stocks jump

* Brexit trade negotiations in focus (Adds comments, updates prices throughout)

By Ambar Warrick and Shreyashi Sanyal

Nov 9 (Reuters) - European shares jumped to an eight-month high on Monday after drugmakers Pfizer and BioNTech flagged strong progress in their COVID-19 vaccine, while Joe Biden's election victory raised hopes of a more stable U.S. trade policy.

Pfizer Inc (NYSE:PFE) PFE.N and BioNTech SE 22UAy.F said the experimental vaccine was more than 90% effective in preventing COVID-19, based on initial data from a large study. pan-European STOXX 600 .STOXX jumped nearly 4% and clocked its best day since late March. Travel and leisure stocks .SXTP , which have been the hardest hit by the pandemic, were among the best performing sectors, adding 7% to hit an eight-month high.

BioNTech's shares jumped more than 15%, while Germany's main stock index .GDAXI added 5%. The index was also boosted by positive trade data for September. on the efficacy of a vaccine is an important piece of the puzzle needed for the global economy and markets to put the COVID-19 recession behind it," said Karen Ward, chief market strategist EMEA at J.P. Morgan Asset Management.

"Coupled with Biden's win, and a more predictable multilateral approach to issues such as trade and climate change, the stage is set for a more balanced return trajectory."

Optimism over a win on Saturday by Democratic candidate Joe Biden in the U.S. election saw European stocks swiftly bouncing back, with the STOXX 600 trading about 11% higher in November so far.

But a resurgence in virus cases had hit markets hard last month, with the STOXX 600 losing more than 5% after the UK, Ireland and France all announced new nation-wide lockdowns.

Investor attention has also been on Brexit trade talks, with Britain saying it was open to a "sensible" compromise on fishing and that there was goodwill on both sides to progress towards a trade deal. export-heavy FTSE 100 .FTSE jumped 4.7%, while the British mid-cap index .FTMC added 5.2%.

In company news, German chipmaker Infineon IFXGn.DE gained 3.5% as it forecast a nearly 23% jump in revenue in the year ahead. homebuilder Taylor Wimpey TW.L surged 18.6% after saying it was set to deliver annual results towards the upper end of expectations as the housing market recovered quicker than expected from a coronavirus-led slump. for STOXX 600 were 2.8 times their 90-day daily average by 1706 GMT as investors stormed to equity markets to play the Biden win trade and a positive COVID-19 vaccine update from Pfizer.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.